Latest Biomolecular Screening Posters
Germline Cytoskeletal and ECM Single Nucleotide Variations (SNVs) are Associated with Distinct Survival Rates: The Prominence of MUC4 Germline SNVsShayan Falasiri, George Blanck
: USF Health Morsani College of Medicine, Tampa, FL more » Correlations among the Toddler Gut Microbiome and Health Status VariablesSamia Dutra1, Maureen Groer, PhD1, Ming Ji, PhD1, Allyson Duffy, PhD1, Kathleen Armstrong, PhD2, Larry Dishaw, PhD2, Elizabeth Miller, PhD3, Alyson Yee4, Jack Gilbert, PhD4
1College of Nursing, 2College of Medicine, and 3Department of Anthropology, University of South Florida, Tampa, FL. 4Argonne National Laboratory, Chicago, IL.more » Screening of ALDH2 Interacting Proteins by Co-Immunoprecipitation and Mass SpectrometryIrene John
University of South Floridamore » 2'-O-methyl phosphorothioate linkage-modified synthetic guide RNAs for efficient CRISPR-Cas9 genome editing and reduced cellular toxicityTiana Stastny, Megan Basila, Hidevaldo B. Machado, Emily Anderson, Eldon T. Chou, Melissa L. Kelley, Anja van Brabant Smith
Dharmacon part of Horizon Discovery Groupmore » P450 INDUCTION IN CRYOPRESERVED HEPATOCYTES FROM PXR AND CAR NUCLEAR RECEPTOR KNOCK-OUT RATSKevin P. Forbes1 , Kirsten Amaral2 and Albert P. Li2
1Horizon Discovery Group Company, Saint Louis, MO 63146 | k.forbes@horizondiscovery.com, more » Potent transcriptional activation using CRISPRa with synthetic crRNAEldon T. Chou, Žaklina Strezoska, Elena Maksimova, Maren M. Gross, Melissa L. Kelley, and Anja van Brabant Smith
Dharmacon part of Horizon Discovery Groupmore » MODEL-AD: Bioinformatics and Data ManagementMODEL-AD: Bioinformatics and Data ManagementBruce Lamb1, Michael Sasner2, Andrew Saykin1, Lara Mangravite3, Gregory Carter2
1Stark Neurosciences Research Institute, Indiana University, Indianapolis, IN USA 2The Jackson Laboratory, Bar Harbor, ME USA 3Sage Bionetworks, Seattle, WA USAmore » MODEL-AD: The Disease Modeling ProjectM.Sasner1, A. Oblak2, H. Williams1, G. Howell1, B.T. Lamb2 and the MODEL-AD consortium
1The Jackson Laboratory, Bar Harbor, ME; 2Stark Neurosciences Research Institute, Indianapolis, IA; Sage Bionetworks, Seattle, WAmore » MODEL-AD: Genetic models of late-onset Alzheimer’s disease*A. OBLAK1,2, G. CARTER3, G. R. HOWELL3, B. LOGSDON4, L. MANGRAVITE4, K. NHO2, L. OMBERG4, K. D. ONOS3, V. PHILIP3, C. PREUSS3, S. J. SUKOFF RIZZO3, M. SASNER3, L. SHEN1,2, A. J. SAYKIN1,2, P. TERRITO1,2, A. UYAR3, H. WILLIAMS3, B. T. LAMB1,5
1STARK Neurosci. Res. Inst., 2Radiology & Imaging Sciences, Indiana University School of Medicine, 3The Jackson Lab., Bar Harbor, ME; 4Sage Bionetworks, Seattle, WA; 5Medical & Molecular Genetics, Indiana University School of Medicinemore » Preclinical drug screening in new generation Alzheimer’s disease mouse models: The MODEL-AD Consortium StrategyP.R. Territo1, S.J. Sukoff Rizzo2, K. Onos2, J.A. Meyer1, J. Peters1, S.C. Persohn1, B.R. McCarthy1, A.A. Riley1, S. Quinney1, D. Jones1, M. Sasner2, G. Howell2, H. Williams2, A.J. Oblak1, B.L. Lamb1 and the MODEL-AD consortium
1Indiana University School of Medicine, Indianapolis, Indiana USA, 2The Jackson Laboratory, Bar Harbor, Maine USAmore » Comparison of Supine / Prone Imaging with Profile Attenuation Correction for Identification and Correction of Attenuation ArtifactsDr. Abdul Rehman Tahir
NHSmore » Artificial multimeric proteins with programmable biological and chemical functionsPiotr M. Skowron, Łukasz Janus, Olga Żołnierkiewicz, Małgorzata Skowron, Joanna Jeżewska-Frąckowiak, Daria Krefft, Dawid Nidzworski, Kasjan Szemiako, Natalia Maciejewska, Marta Nowak, Alicja Wiercińska-Drapało, Grzegorz Węgrzyn, Aneta Szymańska, Agnieszka Żylicz-Stachula
University of Gdansk, Faculty of Chemistry, Dept. of Molecular Biotechnology, Gdansk, Polandmore » ELECTROWETTING CHIP ON PAPER BASED SUBSTRATENurul Amziah Md Yunus and Noor Faezah Ismail
Universiti Putra Malaysiamore » www.thebraindomain.org: Science Writing for Public EngagementBartley, O.; Rienecker, K.; Stickland, R.; Pass, R.; Bunga, A.; Cross, E.; & Fagg, J.
Cardiff University, Wales, UK.more » Quantitative Cell-Based Bioassays for Immunotherapy Programs Targeting Immune Checkpoint Co-Stimulatory ReceptorsJun Wang, Michael Beck, Jamison Grailer, Jim Hartnett, Frank Fan, Mei Cong and Zhi-jie Jey Cheng
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711more » Fc Effector Bioassays for Rapid and Quantitative Measurement of ADCC and ADCP Mechanisms of ActionZhi-jie Jey Cheng, Rich Moravec, Aileen Paguio, Denise Garvin, Frank Fan, and Mei Cong
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711, USAmore » Bioluminescent Assay for GTPases Allows Measurement of GTPase, GAP and GEF ActivitiesSubhanjan Mondal and Said A. Goueli
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI, 53711more » Bioluminescent Kinase Profiling Systems For Characterizing Small Molecule Kinase InhibitorsHicham Zegzouti, Jacquelyn Hennek, Tracy Worzella, Monse Contreras, Cristopher Cowan and Said Goueli
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711more » Universal Homogeneous Bioluminescent Assay to Monitor the Activity of Various Classes of Methyltransferases in vitroMichael Curtin, Kevin Hsiao1, Said A. Goueli1,2
1Research and Development, Promega Corp. Madison, WI 53711, and 2University of Wisconsin School of Medicine and Public Health, Madison, WI 53706more » A Real-Time Annexin V Method for Monitoring Programmed Cell DeathKevin Kupcho1, Andrew Niles1, John Shultz1, Jamison Grailer1, Wenhui Zhou2, Robin Hurst1, Jim Hartnett1, Terry Riss1, Dan Lazar1, and James Cali1
1 Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711; 2 Promega Biosciences LLC, 277 Granada Dr, San Luis Obispo, CA 93401more »
